A A Khaleeli

942 total citations
28 papers, 693 citations indexed

About

A A Khaleeli is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Rheumatology. According to data from OpenAlex, A A Khaleeli has authored 28 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Rheumatology. Recurrent topics in A A Khaleeli's work include Muscle Physiology and Disorders (6 papers), Parathyroid Disorders and Treatments (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). A A Khaleeli is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Parathyroid Disorders and Treatments (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). A A Khaleeli collaborates with scholars based in United Kingdom and Singapore. A A Khaleeli's co-authors include R. H. T. Edwards, W.H. Taylor, Graham McPhail, K. Gohil, Komal Imtiaz, Evan Ross, J M Round, Michael J. Rennie, Jonathan Round and Najma Memon and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Journal of Clinical Pathology and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

A A Khaleeli

28 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A A Khaleeli United Kingdom 13 221 201 122 118 118 28 693
F. D. Rosenthal United Kingdom 19 325 1.5× 142 0.7× 81 0.7× 45 0.4× 105 0.9× 48 913
Yuya Yamada Japan 16 191 0.9× 149 0.7× 73 0.6× 53 0.4× 174 1.5× 80 794
Willy Coopmans Belgium 14 389 1.8× 133 0.7× 85 0.7× 194 1.6× 343 2.9× 15 933
G. Leb Austria 19 231 1.0× 245 1.2× 48 0.4× 55 0.5× 121 1.0× 53 1.1k
J. Caulie Gunnells United States 20 205 0.9× 155 0.8× 339 2.8× 40 0.3× 53 0.4× 38 1.1k
Neşe Özbey Türkiye 19 545 2.5× 77 0.4× 181 1.5× 88 0.7× 108 0.9× 42 1.0k
Engın Güney Türkiye 16 294 1.3× 78 0.4× 68 0.6× 42 0.4× 141 1.2× 52 884
Shuichi Hisanaga Japan 17 63 0.3× 182 0.9× 301 2.5× 49 0.4× 81 0.7× 39 797
K. K. Pun Hong Kong 13 240 1.1× 243 1.2× 65 0.5× 17 0.1× 62 0.5× 41 785
A. Stuart Mason United Kingdom 14 658 3.0× 132 0.7× 30 0.2× 90 0.8× 105 0.9× 43 999

Countries citing papers authored by A A Khaleeli

Since Specialization
Citations

This map shows the geographic impact of A A Khaleeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A A Khaleeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A A Khaleeli more than expected).

Fields of papers citing papers by A A Khaleeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A A Khaleeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A A Khaleeli. The network helps show where A A Khaleeli may publish in the future.

Co-authorship network of co-authors of A A Khaleeli

This figure shows the co-authorship network connecting the top 25 collaborators of A A Khaleeli. A scholar is included among the top collaborators of A A Khaleeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A A Khaleeli. A A Khaleeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ajala, Olubukola, et al.. (2009). Insulin resistance before and after parathyroidectomy in primary hyperparathyroidism. 19(2). 429–30; author reply 429. 2 indexed citations
2.
Ajala, Olubukola, et al.. (2009). Primary hyperparathyroidism: osteopaenia and osteoporosis. 19(20). 14314–20. 1 indexed citations
3.
Khaleeli, A A, et al.. (2006). Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes/Metabolism Research and Reviews. 23(1). 43–48. 47 indexed citations
4.
Moulik, Probal, et al.. (2004). Steroid responsiveness in a case of Riedel's thyroiditis and retroperitoneal fibrosis. International Journal of Clinical Practice. 58(3). 312–315. 14 indexed citations
5.
Sen, Sagnik, et al.. (2004). Comparison of optometry vs digital photography screening for diabetic retinopathy in a single district. Eye. 18(1). 3–8. 11 indexed citations
6.
Moulik, Probal, et al.. (2002). Thyroid dysfunction in diabetes: Can we justify routine screening?. 5 indexed citations
7.
Moulik, Probal, et al.. (2002). An interesting case of thirst and polyuria. Postgraduate Medical Journal. 78(918). 248–248. 1 indexed citations
8.
Taylor, W.H. & A A Khaleeli. (2001). Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes/Metabolism Research and Reviews. 17(3). 175–180. 69 indexed citations
9.
Imtiaz, Komal & A A Khaleeli. (2001). Squamous cell carcinoma developing in necrobiosis lipoidica. Diabetic Medicine. 18(4). 325–328. 30 indexed citations
10.
Imtiaz, Komal, Pamela Monteith, & A A Khaleeli. (2000). Complete histological regression of metastatic carcinoid tumour after treatment with octreotide. Clinical Endocrinology. 53(6). 755–758. 32 indexed citations
11.
Tandon, Shourya, et al.. (1999). Chronic demyelinating polyneuropathy in pregnancy treated with intravenous immunoglobulin. BJOG An International Journal of Obstetrics & Gynaecology. 106(2). 174–176. 4 indexed citations
12.
Taylor, W.H. & A A Khaleeli. (1997). Prevalence of Primary Hyperparathyroidism in Patients with Diabetes Mellitus. Diabetic Medicine. 14(5). 386–389. 37 indexed citations
13.
Khaleeli, A A, D. J. Betteridge, R. H. T. Edwards, J M Round, & Evan Ross. (1983). EFFECT OF TREATMENT OF CUSHING'S SYNDROME ON SKELETAL MUSCLE STRUCTURE AND FUNCTION. Clinical Endocrinology. 19(4). 547–556. 19 indexed citations
14.
Edwards, R. H. T., A A Khaleeli, & K. R. Mills. (1983). Muscle Function in Endocrine and Metabolic Myopathy. Seminars in Neurology. 3(3). 294–307. 3 indexed citations
15.
Khaleeli, A A, et al.. (1983). THE CLINICAL PRESENTATION OF HYPOTHYROID MYOPATHY AND ITS RELATIONSHIP TO ABNORMALITIES IN STRUCTURE AND FUNCTION OF SKELETAL MUSCLE. Clinical Endocrinology. 19(3). 365–376. 86 indexed citations
16.
Khaleeli, A A, J M Round, Michael J. Rennie, & R. H. T. Edwards. (1982). Effect of treatment on muscle structure and function in hypo thyroid myopathy. 2. 19. 3 indexed citations
17.
Khaleeli, A A & Najma Memon. (1982). Factors affecting resolution of pericardial effusions in primary hypothyroidism: a clinical, biochemical and echocardiographic study. Postgraduate Medical Journal. 58(682). 473–476. 29 indexed citations
18.
Khaleeli, A A. (1978). Myxoedema coma. A report on five successfully treated cases. Postgraduate Medical Journal. 54(638). 825–829. 6 indexed citations
19.
Khaleeli, A A & A Wyman. (1978). Hyperosmolar non-ketotic diabetic coma induced by furosemide in modest dosage. Postgraduate Medical Journal. 54(627). 43–44. 7 indexed citations
20.
Khaleeli, A A. (1976). Quinaband-induced thrombocytopenic purpura in a patient with myxoedema coma.. BMJ. 2(6035). 562–563. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026